InvestorsHub Logo
icon url

Gator328

01/05/21 12:52 PM

#291738 RE: bas2020 #291685

I also am hopeful that Anavex prevails in the end. I’m more cautiously optimistic than many here because I don’t feel we are out of the woods yet. We may have a clearer path out but until the primary endpoints are met in a Phase 3 trial, nothing is for certain. Not even Anavex.

And it’s this remaining uncertainty that is suppressing the stock price. It’s so easy for an executive to lose his or her job paying billions for a drug that isn’t proven yet. As long as big pharma is on the sidelines, Anavex will remain primarily a retail-driven stock. If/when we get approval is when conservative funds will want our shares.

There haven’t been hit pieces or multitudes of damaging tweets in recent years like in 2015/2016. Whatever remnants of the cabal exist today are a shell of its old self. The price action, up and down, is retail buyers and sellers betting on the remaining uncertainty.